-
Multiple myeloma treatment receives Orphan Drug Designation
europeanpharmaceuticalreview
September 03, 2019
Orphan drug designation has been granted to the CT053 anti-BCMA CAR-T program for multiple myeloma treatment.
-
Unique hydrogel strategy aids the delivery of drugs
europeanpharmaceuticalreview
September 02, 2019
Scientists have developed a hydrogel-based carrier that can deliver siRNAs directly to where they are needed.
-
Antibody Drug Conjugates Market to Be Worth $15bn by 2030
europeanpharmaceuticalreview
September 02, 2019
Antibody drug conjugates are presently recognised as a potent class of targeted anticancer therapies which will result in growth in the market.
-
Small molecules dominate FDA drug approvals this month
europeanpharmaceuticalreview
September 02, 2019
This August saw nine new green lights from the FDA, all small molecules, which makes up a third of the approvals this year.
-
For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years
drugs
August 30, 2019
Medicare patients with multiple sclerosis (MS) saw their medication costs soar by more than sevenfold over a decade, a new study finds.
-
FDA: Risk From Tainted Blood Pressure Drugs Very Low
drugs
August 30, 2019
The health risk from contamination of widely used generic blood pressure medications, angiotensin II receptor blockers, is very low, according to the U.S. Food and Drug Administration.
-
China to relax generic drug import laws
europeanpharmaceuticalreview
August 29, 2019
The government in China has stated that small quantities of generic medicines that are legal in foreign countries will no longer be classed as “fake drugs”.
-
Significant number of drugs on the market not yet fully approved
europeanpharmaceuticalreview
August 29, 2019
A large number of drug manufacturers are failing to complete the FDA’s Accelerated Approval Program, meaning not all available drugs are fully approved, finds a study.
-
Drug makers file complaint for regulations to lower Canadian drug prices
europeanpharmaceuticalreview
August 29, 2019
Five pharma companies have filed a complaint in Canadian court over new rules intended to lower the price of drugs in the country.
-
A new drug could revolutionize the treatment of neurological disorders
worldpharmanews
August 29, 2019
The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may prevent neuronal death...